News & Updates

In a significant advancement for women's health, BD today announced FDA approval for the use of self-collected vaginal specimens for HPV testing, allowing women to self-collect vaginal samples for human papillomavirus (HPV) testing in a health care setting, which could include non-traditional locations such as a retail pharmacy or mobile clinic. This new approval of self-collected samples opens the door to a less invasive testing option and improves access to testing for individuals who face barriers to cervical cancer screening.

A Harris Poll commissioned by BD of women in the U.S., U.K. and Sweden shines a spotlight on the differences in access to cervical cancer screening and prevention.

Featured in FiercePharma, new Harris Poll findings reveal women want to be more informed by their HCPs when it comes to STIs, testing and treatment options.

BD released findings from a survey conducted online by The Harris Poll, reporting that women feel less knowledgeable about testing and treatment options for sexually transmitted infections (STIs) compared to other vaginal diseases and infections.

Dr. Jeff Andrews, VP Medical Affairs, Integrated Diagnostic Solutions, shares statistics with Business Insider about knowledge gaps in cervical cancer causes and tests.

The BD Onclarity™ HPV Assay has received FDA Approval for use with both BD SurePath™ Liquid-based Pap Test and Hologic ThinPrep® Pap Test, which expands access to the HPV test that more precisely identifies patients’ risk for cervical cancer.

In Contemporary OB/GYN, Dr. Jeff Andrews, VP Medical Affairs, shares findings from a Harris Poll noting gaps in women's knowledge about HPV and cervical cancer.

Dr. Jeff Andrews, VP Medical Affairs, Integrated Diagnostic Solutions, shares insights in POLITICO from a survey conducted by The Harris Poll noting significant gaps in women’s understanding about the causes and prevention of cervical cancer.

In this Fast Company op-ed, Brooke Story, BD Integrated Diagnostic Solutions president, challenges and encourages the advocacy for strengthening health care systems, improving testing infrastructure and delivering the highest quality care, regardless of race, geographic location, or socioeconomic status.

BD released findings from a survey conducted by The Harris Poll that indicate a significant gap in women’s knowledge about the primary causes of cervical cancer as well as the most effective means of prevention.